This report responds to the December 2016 “Expanding Capacity for Health Outcomes (ECHO) Act,” Public Law 114-270, which requires the Department to report to Congress on a range of issues related to technology-enabled collaborative learning and capacity building models and make recommendations on their use. This report consists of a summary document that includes the Department’s recommen
Health & Health Care
ASPE produces health policy research with a focus on equity, coverage, and access. Find resources related to a broad range of topics, including the uninsured population, vaccine hesitancy, Medicaid/CHIP, Medicare, the federal marketplace (HealthCare.gov), telehealth, health care delivery, underserved areas, delivery system transformation, health outcomes, and social determinants of health.
Noteworthy Resources and Reports
Vaccine Hesitancy for COVID-19: State, County, and Local Estimates
To support state and local communication and outreach efforts, ASPE developed state, county, and sub-state level predictions of hesitancy rates using the most recently available federal survey data. Explore the interactive map and other resources.
Topic Areas
Reports
Displaying 351 - 360 of 1485. 10 per page. Page 36.
Advanced SearchReport to Congress
Report to Congress: Current State of Technology-Enabled Collaborative Learning and Capacity Building Models
Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report
ABSTRACT
ASPE Issue Brief
Housing and Delivery System Reform Collaborations: Issue Brief
This project examined current collaborations between housing providers and health care providers. Recent delivery system reforms have provided new or expanded opportunities at the state, local, and organizational level to forge collaborations between health care and housing providers.
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Out-of-Pocket Costs
This project assessed changes in opioid use disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market during 2007 and 2014.
Final Outcome Evaluation of the Balancing Incentive Program
This is the final report of the Balancing Incentive Program evaluation. Five earlier progress reports on the Balancing Incentive Program (BIP) have already been published. The BIP, legislated in the 2010 Affordable Care Act, offered states temporary enhanced federal financial participation for Medicaid home and community-based services (HCBS).
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Final Report
This project assessed changes in Opioid Use Disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market at two timepoints, 2006-2007 and 2014-2015, that mark the periods before and after implementation of the Mental Health Parity and Addiction Equity Act (MHPAEA), the Affordable Care Act, the introduction and expanded use of new opioid treatme
Perspectives of Physicians in Small Rural Practices on the Medicare Quality Payment Program
The objectives of this research effort were to collect feedback through interviews with physicians in small rural practices on the initial implementation of Medicare’s Quality Payment Program in 2017, a new value-based purchasing program for Medicare physicians.
Aligning Federal Performance Indicators Across Programs Promoting Self-Sufficiency: Local Perspectives
Individuals and families frequently qualify for multiple human services and employment programs that are funded, regulated, and administered by different federal agencies—each with their own eligibility criteria, program requirements, and performance indicators.
Prescription Drug Pricing: ASPE Resources Related to Safe Harbor Rule
Department of Health and Human Services Secretary Alex Azar and Inspector General Daniel Levinson have issued a proposed rule, “Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in